Clinical Trials · NCT06485089
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- University of Kansas Medical Center
- Enrollment
- 25
- Start date
- Sep 2024
- Locations
- 2 sites, United States
- Primary endpoint
- Feasibility of design as assessed by accrual rate of 1 or more per month over 12 months